Safety and effectiveness of tolvaptan for fluid management after pediatric cardiovascular surgery

被引：0
|
作者：
Yuzo Katayama
Tsukasa Ozawa
Noritsugu Shiono
Hiroshi Masuhara
Takeshiro Fujii
Yoshinori Watanabe
机构：
[1] Toho University Omori Medical Center,Division of Cardiovascular Surgery, Department of Surgery
来源：
General Thoracic and Cardiovascular Surgery | 2017年 / 65卷
关键词：
Diuretics; Tolvaptan; Surgery; Congenital heart disease;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：622 / 626
页数：4
相关论文
共 50 条
  • [1] Safety and effectiveness of tolvaptan for fluid management after pediatric cardiovascular surgery
    Katayama, Yuzo
    Ozawa, Tsukasa
    Shiono, Noritsugu
    Masuhara, Hiroshi
    Fujii, Takeshiro
    Watanabe, Yoshinori
    GENERAL THORACIC AND CARDIOVASCULAR SURGERY, 2017, 65 (11) : 622 - 626
  • [2] Predictive factors for responders to tolvaptan in fluid management after cardiovascular surgery
    Takashi Kido
    Hiroyuki Nishi
    Koichi Toda
    Takayoshi Ueno
    Toru Kuratani
    Masayuki Sakaki
    Toshiki Takahashi
    Yoshiki Sawa
    General Thoracic and Cardiovascular Surgery, 2017, 65 : 110 - 116
  • [3] Predictive factors for responders to tolvaptan in fluid management after cardiovascular surgery
    Kido, Takashi
    Nishi, Hiroyuki
    Toda, Koichi
    Ueno, Takayoshi
    Kuratani, Toru
    Sakaki, Masayuki
    Takahashi, Toshiki
    Sawa, Yoshiki
    GENERAL THORACIC AND CARDIOVASCULAR SURGERY, 2017, 65 (02) : 110 - 116
  • [4] Efficacy and safety of tolvaptan after pediatric congenital heart disease surgery
    Kojima, Takuro
    Kanai, Azusa
    Yoshiba, Shigeki
    Kobayashi, Toshiki
    Sumitomo, Naokata
    HEART AND VESSELS, 2021, 36 (05) : 717 - 723
  • [5] Efficacy and safety of tolvaptan after pediatric congenital heart disease surgery
    Takuro Kojima
    Azusa Kanai
    Shigeki Yoshiba
    Toshiki Kobayashi
    Naokata Sumitomo
    Heart and Vessels, 2021, 36 : 717 - 723
  • [6] Effects of tolvaptan in the early postoperative stage after heart valve surgery: results of the STAR (Study of Tolvaptan for fluid retention AfteR valve surgery) trial
    Hiroyuki Nishi
    Koichi Toda
    Shigeru Miyagawa
    Yasushi Yoshikawa
    Satsuki Fukushima
    Masashi Kawamura
    Daisuke Yoshioka
    Tetsuya Saito
    Takayoshi Ueno
    Toru Kuratani
    Yoshiki Sawa
    Surgery Today, 2015, 45 : 1542 - 1551
  • [7] Efficacy of tolvaptan for fluid management after cardiovascular surgery: A systematic review and meta-analysis of randomized control trials
    Chen, Huiling
    Jiang, Weihong
    Li, Xiaogang
    Meng, Zhaohui
    Chen, Huamei
    Li, Jiaying
    Wang, Junwen
    Zhao, Xiexiong
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2020, 20 (03) : 2585 - 2592
  • [8] Effectiveness and safety of Tolvaptan in infants with congenital heart disease
    Sakaguchi, Haruhide
    Hirano, Daishi
    Saito, Aya
    Takemasa, Yoichi
    Umeda, Chisato
    Miwa, Saori
    Ito, Akira
    Oishi, Kimihiko
    PEDIATRICS INTERNATIONAL, 2023, 65 (01)
  • [9] Comparative Safety and Effectiveness of Urea and Tolvaptan for the Management of Hyponatremia
    Scalla, Paolo A.
    Palma, Stephanie M.
    Dittmar, Erika
    Zamora, Francis J.
    Trimino, Estela
    JOURNAL OF PHARMACY PRACTICE, 2024, 37 (06) : 1252 - 1257
  • [10] Effects of tolvaptan in the early postoperative stage after heart valve surgery: results of the STAR (Study of Tolvaptan for fluid retention AfteR valve surgery) trial (vol 45, pg 1542, 2015)
    Nishi, Hiroyuki
    Toda, Koichi
    Miyagawa, Shigeru
    Yoshikawa, Yasushi
    Fukushima, Satsuki
    Kawamura, Masashi
    Yoshioka, Daisuke
    Saito, Tetsuya
    Ueno, Takayoshi
    Kuratani, Toru
    Sawa, Yoshiki
    SURGERY TODAY, 2015, 45 (12) : 1552 - 1552
12345